Hepatreat Sachet Orange

Introduction

Hepatreat Sachet Orange is a prescription medication that contains the active ingredients L-Ornithine L-Aspartate. This medication is commonly known by its generic name and is available under the brand name Hepatreat Sachet Orange.

Uses

Hepatreat Sachet Orange is primarily prescribed for the treatment of liver diseases such as cirrhosis and hepatic encephalopathy. It is also used to improve liver function and reduce ammonia levels in the body.

Dosage and Administration

The recommended dosage of Hepatreat Sachet Orange may vary depending on the severity of the liver condition and individual patient factors. Follow the instructions provided by your healthcare professional. Generally, the medication is taken orally by dissolving the contents of one sachet in a glass of water. It is usually taken once or twice daily, with or without food.

Mechanism of Action

Hepatreat Sachet Orange works by promoting the detoxification process in the liver. The active ingredients, L-Ornithine and L-Aspartate, help in the breakdown of ammonia, a toxic substance that can accumulate in the body due to liver dysfunction. By reducing ammonia levels, Hepatreat Sachet Orange supports the proper functioning of the liver.

Side Effects

Common side effects of this medication may include diarrhea, nausea, vomiting, stomach discomfort, and changes in taste. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, consult your healthcare professional.

Drug Interactions

Hepatreat Sachet Orange may interact with certain medications. Inform your healthcare professional about all the medications, supplements, and herbal products you are currently taking. Some medications that may interact with Hepatreat Sachet Orange include certain antibiotics, antacids, and medications that affect liver function. Your healthcare professional will consider these interactions and adjust your treatment plan accordingly.

Precautions

Before starting Hepatreat Sachet Orange, inform your healthcare professional about any existing medical conditions, allergies, or medications you are taking. This medication may not be suitable for individuals with certain liver diseases or kidney problems. Avoid alcohol consumption while taking Hepatreat Sachet Orange, as it can worsen liver damage.

Storage

Hepatreat Sachet Orange should be stored at room temperature, away from direct sunlight and moisture. Keep this medication out of reach of children and pets. Do not use Hepatreat Sachet Orange if the sachet is damaged or expired. Proper storage helps maintain the effectiveness and safety of the medication.

Patient Tips

• Take Hepatreat Sachet Orange as prescribed by your healthcare professional. Do not exceed the recommended dosage.
• If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• maintain a healthy lifestyle while taking Hepatreat Sachet Orange. This includes following a balanced diet, getting regular exercise, and avoiding excessive alcohol consumption.
• If you have any questions or concerns about Hepatreat Sachet Orange, don’t hesitate to consult your healthcare professional. They are best equipped to provide personalized advice and guidance based on your specific medical needs.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Low blood sugar (hypoglycaemia) (NHS UK) [Accessed 3 Jun. 2024] (online) Available at:
• Numeta G13%E Preterm, emulsion for infusion (Health Professionals SmPC) Available at:
• Hepa-Merz (International database) (Drugs.com) [Accessed 21 Jun. 2024] (online) Available at:
• OTC gene (MedlinePlus) [Accessed 4 Jun. 2024] (online) Available at:
• Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial. Hepatology. 2022 May;75(5):1194-1203. doi: 10.1002/hep.32255. Epub 2021 Dec 21. [Accessed 13 Jun. 2024] Available at: